"Healthcare today certainly falls far short of the vision portrayed in Star Trek," Paul Jacobs, the head of Qualcomm, says. But by partnering with the X Prize Foundation, his firm hopes to drive medical technology in that direction.
In The News
Fred Giovannitti is that rarity: a man who divides his time between two extremely disparate careers. Giovannitti makes his living giving tattoos to discerning customers in Las Vegas, but he also spends a considerable amount of time as the creative...
But this is Peter Diamandis, the fast-talking, hand-chopping impresario of the tech and space worlds. “The system is broken, access to health care is inconvenient, inefficient, bureaucratic—at worst, it’s even inaccurate,” he intones, striding on the...
In 2004, thousands showed up in Mojave, California for the triumphant launch of SpaceShipOne as part of the Ansari X PRIZE competition. If you had asked them what they viewed as the next big challenge in commercial spaceflight, many would have said: “...
Designer Burt Rutan, billionaire Paul Allen, rocketman Elon Musk and former NASA boss Mike Griffin are teaming to develop an air-launch rocket system that would use a super aircraft the size of two 747s to carry a liquid-fueled SpaceX booster to 30,...
Designer Burt Rutan, billionaire Paul Allen, rocketman Elon Musk and former NASA boss Mike Griffin are teaming to develop an air-launch rocket system that would use a super aircraft the size of two 747s to carry a liquid-fueled SpaceX booster to 30,...
The Archon Genomics X-Prize is offering $10 million to the first research team to sequence the genomes of 100 people who are age 100 or older. The goal: Get a clear view, for the first time, of what makes centenarians different on a genetic level.
The Archon Genomics X-Prize is offering $10 million to the first research team to sequence the genomes of 100 people who are age 100 or older. The goal: Get a clear view, for the first time, of what makes centenarians different on a genetic level.
Although Perls and his peers around the world have been looking at centenarian DNA for decades, a much more focused project is now getting underway: the Archon Genomic X Prize (AGXP). This bold endeavour seeks to find a fast and cheap way to sequence...
Although Perls and his peers around the world have been looking at centenarian DNA for decades, a much more focused project is now getting underway: the Archon Genomic X Prize (AGXP). This bold endeavour seeks to find a fast and cheap way to sequence...







